Novellia, Inc.

Based in the US, Novellia, Inc. is a software company that specializes in providing a personal health records platform to empower individuals in managing their healthcare information securely. Founded in 2023, Novellia, Inc. operates as a personal health records platform that consolidates medical information for users.

The company raised USD 18 mn in Series A funding on June 2, 2026, led by Spark Capital and joined by Acrew Capital, Bling Capital, Khosla Ventures, and TMV. The founder's history is not detailed, nor is there mention of any subsidiaries or previous mergers. Novellia offers a personal health records platform designed to empower individuals by consolidating their medical information in one secure location. The core service enables users to gather, manage, and advocate for their health through a comprehensive tool that integrates records from over 50,000 healthcare systems.

Users can upload documents, digitize paper records, and track symptoms and medications, addressing the need for organized and accessible health information. Currently, Novellia's services are available in the United States, primarily targeting individuals who value privacy and seek control over their healthcare. Novellia operates a business model that is entirely free for patients, with funding derived from partnerships in healthcare research with biopharmaceutical companies. These partnerships leverage de-identified and aggregated data to support research initiatives.

There are no subscription fees, hidden charges, or advertisements that create barriers for users. Novellia’s flagship offering is its personal health records platform, which serves as a vital resource for patients looking to consolidate their healthcare information. In June 2026, Novellia, Inc. raised USD 18 mn in Series A funding, which will be utilized to scale its technology, launch a mobile app, and expand its data platform for patient records and research use.

The company aims to enhance its offerings and possibly expand into additional markets, although specific regions for expansion have not been disclosed.